E
Entia Biosciences Inc
OTC:ERGO
Entia Biosciences Inc
OTC:ERGO
Price:
0.0001
USD
Market Closed
Market Cap:
$3.4k
Balance Sheet
Balance Sheet Decomposition
Entia Biosciences Inc
Entia Biosciences Inc
Balance Sheet Decomposition is not available for
Entia Biosciences Inc
Entia Biosciences Inc
Balance Sheet
Entia Biosciences Inc
Entia Biosciences Inc
Currency: USD
| Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
1
N/A
|
1
N/A
|
0
-12%
|
0
-8%
|
0
+14%
|
1
+36%
|
1
+38%
|
0
-48%
|
0
-2%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
1
|
1
|
1
|
2
|
1
|
1
|
2
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
+133%
|
1
+436%
|
1
-11%
|
1
+67%
|
2
+42%
|
1
-38%
|
1
+26%
|
2
+94%
|
|
| Equity | ||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
1
|
2
|
4
|
5
|
9
|
11
|
13
|
14
|
|
| Additional Paid In Capital |
1
|
1
|
2
|
4
|
5
|
8
|
11
|
12
|
12
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
-16%
|
0
N/A
|
0
+16%
|
1
-150%
|
1
-46%
|
0
+88%
|
1
-579%
|
2
-149%
|
|
| Total Liabilities & Equity |
1
N/A
|
1
N/A
|
0
-12%
|
0
-8%
|
0
+14%
|
1
+36%
|
1
+38%
|
0
-48%
|
0
-2%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
5
|
5
|
6
|
7
|
7
|
8
|
16
|
28
|
28
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
